首页> 外文期刊>Annals of Surgery >Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
【24h】

Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.

机译:无论肿瘤的临床表现如何,印戒细胞组织学是胃腺癌预后不良的独立预测因子。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To test the hypothesis that signet ring cell (SRC) histology has a negative prognostic value in patients with gastric adenocarcinoma (ADC). SUMMARY BACKGROUND DATA: In western countries, gastric ADC with SRC often occurs after the disease has advanced. Consequently, the prognosis of SRC is generally regarded as poor, although survival studies comparing SRC and non-SRC have yielded inconsistent results. METHODS:: An intent to treat analysis was performed among 215 patients with gastric ADC scheduled for surgical resection from 1996 to 2007. Of these, 180 patients underwent the resection and 35 were not resected due to diffuse metastatic illness. From 59 resected patients with SRC (SRC group), control non-SRC resected patients matched by age, gender, American Society of Anaesthesiologists (ASA) classification, tumoral location, and pTNM stage were randomly selected by computer (non-SRC group: n = 100) during the same study period. RESULTS: The overall median survival was 21 months, which was significantly higher in resected compared to non-resected patients (31 vs. 5 months, P < 0.001). In non-resected patients, SRC histological subtype was associated with higher rates of diffuse peritoneal carcinomatosis (90.1% vs. 62.5%, P = 0.053) and neoplastic ascitis (63.6% vs. 34.7%, P = 0.059) and poorer median survival (5 vs. 7 months, P = 0.062). For resected patients, the 2 groups (SRC and non-SRC) were comparable regarding matching variables, demographic variables, and postoperative course. The median survival was significantly lower for SRC patients (21 vs. 44 months, P = 0.004). SRC resected patients exhibited higher rates of localized peritoneal carcinomatosis (P = 0.013) and lymph node involvement (P < 0.001) at diagnosis, lower R0 resection rate (P = 0.019) and earlier tumor relapse (P = 0.009), which was generally in a peritoneal carcinomatosis form (P = 0.011). By multivariate analysis, we concluded that SRC histology was independently associated with a dismal prognosis after adjustment on confounding variables (hazard ratio = 1.5, 95% confidence interval 1.1-2.0, P = 0.004). The prognostic role of SRC was maintained after exclusion of patients with advanced stage at initial diagnosis such as localized peritoneal carcinomatosis or lymph node invasion. CONCLUSIONS: This study is currently the best evidence showing that SRC is a major and independent predictor of poor prognosis due to specific characteristics such as more infiltrating tumors showing affinity for lymphatic tissue accompanied by a higher rate of peritoneal carcinomatosis. Our results suggest the need for a specific therapeutic strategy for such tumors.
机译:目的:验证印记环细胞(SRC)组织学对胃腺癌(ADC)患者预后不良的假说。概述背景数据:在西方国家,患有SRC的胃ADC通常在疾病发展后发生。因此,尽管比较SRC和非SRC的生存率研究得出不一致的结果,但SRC的预后通常被认为是差的。方法:对打算在1996年至2007年进行手术切除的215例胃ADC患者进行治疗意向分析。其中180例接受了手术切除,而35例因弥漫性转移性疾病未切除。从年龄,性别,美国麻醉医师学会(ASA)分类,肿瘤位置和pTNM分期匹配的59例SRC切除患者(SRC组)中,通过计算机随机选择对照非SRC切除患者(非SRC组:n = 100)。结果:总体中位生存期为21个月,与未切除的患者相比,切除后的中位生存期显着更高(31 vs. 5个月,P <0.001)。在未切除的患者中,SRC组织学亚型与弥漫性腹膜癌的发生率较高(90.1%对62.5%,P = 0.053)和赘生物性腹膜炎(63.6%对34.7%,P = 0.059)和中位生存期差( 5比7个月,P = 0.062)。对于切除的患者,两组在匹配变量,人口统计学变量和术后病程方面具有可比性。 SRC患者的中位生存期显着降低(21个月对44个月,P = 0.004)。 SRC切除患者在诊断时表现出较高的局部腹膜癌病发生率(P = 0.013)和淋巴结受累(P <0.001),较低的R0切除率(P = 0.019)和较早的肿瘤复发(P = 0.009),通常在腹膜癌的形式(P = 0.011)。通过多变量分析,我们得出结论,在对混杂变量进行调整(危险比= 1.5,95%置信区间1.1-2.0,P = 0.004)后,SRC组织学与预后不良相关。 SRC的预后作用在排除早期诊断如晚期腹膜癌或淋巴结浸润的晚期患者后得以维持。结论:目前这项研究是最好的证据,表明由于特殊特征,如更多浸润性肿瘤对淋巴组织有亲和力并伴有更高的腹膜癌发生率,SRC是不良预后的主要且独立的预测因子。我们的结果表明需要针对此类肿瘤的特定治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号